Zai Lab (ZLAB) Long-Term Investments (2016 - 2024)
Zai Lab (ZLAB) reported Long-Term Investments of $3.1 million for Q4 2024, down 66.21% on a YoY basis from $9.2 million in Q1 2024, and down 1.21% sequentially from $3.2 million in Q3 2024.
Zai Lab (ZLAB) Long-Term Investments (2016 - 2024) Analysis & Trends
Zai Lab (ZLAB) has 9 years of Long-Term Investments data on file, last reported at $3.1 million in Q4 2024.
- For the quarter ending Q4 2024, Long-Term Investments fell 66.21% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2024 stood at $3.1 million (down 66.21% YoY), and the FY2024 full-year result was $3.1 million, down 66.21% from the prior year.
- Long-Term Investments eased to $3.1 million in Q4 2024, from $3.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $20.8 million in Q3 2021 to a low of $1.1 million in Q2 2021.
- A 5-year average of $6.6 million and a median of $4.5 million in 2023 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments soared 1120.09% in 2021 and tumbled 84.06% in 2022, its largest moves.
- Tracing ZLAB's Long-Term Investments over 5 years: stood at $1.3 million in 2020, then soared by 1120.09% to $15.6 million in 2021, then sank by 58.79% to $6.4 million in 2022, then jumped by 43.37% to $9.2 million in 2023, then sank by 66.21% to $3.1 million in 2024.
- Business Quant data shows ZLAB's Long-Term Investments at $3.1 million in Q4 2024, $3.2 million in Q3 2024, and $4.1 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 505,194.89 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 14.11 Mn |
| Dec 31, 2023 | 9.22 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 6.43 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 8.44 Mn |
| Dec 31, 2021 | 15.61 Mn |
| Sep 30, 2021 | 20.80 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 1.28 Mn |
| Dec 31, 2019 | 2.40 Mn |
| Dec 31, 2018 | 3.15 Mn |
| Dec 31, 2017 | 1.65 Mn |